Literature DB >> 21265735

Effective siRNA delivery and target mRNA degradation using an amphipathic peptide to facilitate pH-dependent endosomal escape.

René Bartz1, Haihong Fan, Jingtao Zhang, Nathalie Innocent, Craig Cherrin, Stephen C Beck, Yi Pei, Aaron Momose, Vasant Jadhav, David M Tellers, Fanyu Meng, Louis S Crocker, Laura Sepp-Lorenzino, Stanley F Barnett.   

Abstract

Effective delivery of siRNA (small interfering RNA) into the cells requires the translocation of siRNA into the cytosol. One potential delivery strategy uses cell-delivery peptides that facilitate this step. In the present paper, we describe the characterization of an amphipathic peptide that mediates the uptake of non-covalently bound siRNA into cells and its subsequent release into the cytosol. Biophysical characterization of peptide and peptide/siRNA mixtures at neutral and lysosomal (acidic) pH suggested the formation of α-helical structure only in endosomes and lysosomes. Surprisingly, even though the peptide enhanced the uptake of siRNA into cells, no direct interaction between siRNA and peptide was observed at neutral pH by isothermal titration calorimetry. Importantly, we show that peptide-mediated siRNA uptake occurred through endocytosis and, by applying novel endosomal-escape assays and cell-fractionation techniques, we demonstrated a pH-dependent alteration in endosome and lysosome integrity and subsequent release of siRNA and other cargo into the cytosol. These results indicate a peptide-mediated siRNA delivery through a pH-dependent and conformation-specific interaction with cellular membranes and not with the cargo.

Mesh:

Substances:

Year:  2011        PMID: 21265735     DOI: 10.1042/BJ20101021

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  27 in total

1.  Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape.

Authors:  Jerome Gilleron; William Querbes; Anja Zeigerer; Anna Borodovsky; Giovanni Marsico; Undine Schubert; Kevin Manygoats; Sarah Seifert; Cordula Andree; Martin Stöter; Hila Epstein-Barash; Ligang Zhang; Victor Koteliansky; Kevin Fitzgerald; Eugenio Fava; Marc Bickle; Yannis Kalaidzidis; Akin Akinc; Martin Maier; Marino Zerial
Journal:  Nat Biotechnol       Date:  2013-06-23       Impact factor: 54.908

Review 2.  Getting across the cell membrane: an overview for small molecules, peptides, and proteins.

Authors:  Nicole J Yang; Marlon J Hinner
Journal:  Methods Mol Biol       Date:  2015

Review 3.  Peptide carriers to the rescue: overcoming the barriers to siRNA delivery for cancer treatment.

Authors:  James C Cummings; Haiwen Zhang; Andrew Jakymiw
Journal:  Transl Res       Date:  2019-07-29       Impact factor: 7.012

4.  Charge-altering releasable transporters (CARTs) for the delivery and release of mRNA in living animals.

Authors:  Colin J McKinlay; Jessica R Vargas; Timothy R Blake; Jonathan W Hardy; Masamitsu Kanada; Christopher H Contag; Paul A Wender; Robert M Waymouth
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-09       Impact factor: 11.205

5.  Computational design and experimental characterization of peptides intended for pH-dependent membrane insertion and pore formation.

Authors:  Yao Zhang; René Bartz; Gevorg Grigoryan; Michael Bryant; Jeff Aaronson; Stephen Beck; Nathalie Innocent; Lee Klein; William Procopio; Tom Tucker; Vasant Jadhav; David M Tellers; William F DeGrado
Journal:  ACS Chem Biol       Date:  2015-01-28       Impact factor: 5.100

6.  The targeted intracellular delivery of cytochrome C protein to tumors using lipid-apolipoprotein nanoparticles.

Authors:  Sang Kyoon Kim; Michael B Foote; Leaf Huang
Journal:  Biomaterials       Date:  2012-02-25       Impact factor: 12.479

Review 7.  Uniqueness, advantages, challenges, solutions, and perspectives in therapeutics applying RNA nanotechnology.

Authors:  Peixuan Guo; Farzin Haque; Brent Hallahan; Randall Reif; Hui Li
Journal:  Nucleic Acid Ther       Date:  2012-08       Impact factor: 5.486

Review 8.  Technologies for investigating the physiological barriers to efficient lipid nanoparticle-siRNA delivery.

Authors:  Bin Shi; Marc Abrams
Journal:  J Histochem Cytochem       Date:  2013-03-14       Impact factor: 2.479

9.  CRISPR-delivery particles targeting nuclear receptor-interacting protein 1 (Nrip1) in adipose cells to enhance energy expenditure.

Authors:  Yuefei Shen; Jessica L Cohen; Sarah M Nicoloro; Mark Kelly; Batuhan Yenilmez; Felipe Henriques; Emmanouela Tsagkaraki; Yvonne J K Edwards; Xiaodi Hu; Randall H Friedline; Jason K Kim; Michael P Czech
Journal:  J Biol Chem       Date:  2018-09-06       Impact factor: 5.157

10.  Intracellular delivery and trafficking dynamics of a lymphoma-targeting antibody-polymer conjugate.

Authors:  Geoffrey Y Berguig; Anthony J Convertine; Julie Shi; Maria Corinna Palanca-Wessels; Craig L Duvall; Suzie H Pun; Oliver W Press; Patrick S Stayton
Journal:  Mol Pharm       Date:  2012-11-05       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.